{"schema":"rootz.ai/sec-company/v1","layer":1,"cik":"0001863127","name":"Tyra Biosciences, Inc.","summary":"Tyra Biosciences is a clinical-stage biotechnology company developing next-generation precision medicines targeting FGFR biology for oncology and genetically defined conditions. Its lead product, oral dabogratinib (formerly TYRA-300), is an FGFR3-selective inhibitor in Phase 2 trials for low-grade upper tract urothelial carcinoma, intermediate risk non-muscle invasive bladder cancer, and achondroplasia. The company also has TYRA-430 (FGFR4/3 biased, Phase 1 for HCC) and TYRA-200 (FGFR1/2/3 inhibitor, Phase 1 for ICC). All assets are developed in-house using its proprietary SNP platform.","people":[],"products":[{"name":"Oral dabogratinib (formerly TYRA-300)","type":"platform","description":"FGFR3-selective oral small molecule inhibitor in Phase 2 trials for LG-UTUC, IR NMIBC, and achondroplasia in children."},{"name":"TYRA-430","type":"platform","description":"FGFR4/3-biased oral small molecule inhibitor in Phase 1 trial (SURF431) for FGF19+ hepatocellular carcinoma."},{"name":"TYRA-200","type":"platform","description":"FGFR1/2/3 inhibitor designed to address acquired resistance mutations, in Phase 1 trial (SURF201) for FGFR2-driven ICC."},{"name":"SNP Platform","type":"platform","description":"Proprietary drug design platform using protein crystallography, cell-based assays, and in vivo models for rapid iterative molecular design."}],"partnerships":[],"affiliations":[],"origin":{"leaf":"ab0d28c9357f65b4aa1f388bcd26ece7672b7101c2afbd7d8ca055929356e496","formula":"v2: sha256( sha256(content) || parent || source_accession )","content_sha256":"9b65cdd0e48a651399a899fa606212795dd658b67e5bf6374313c0b3289c222d","parent":"38c780ccca39418d2d8ba59dd246873f915b3aac500ca6c85a327e9a1f026f36","source":"0001193125-26-085490","chain":"sec.gov/EDGAR (retrieved over TLS, accession recorded) > origin.rootz.global extraction > this response","registry":"origin.rootz.global","verify":"Recompute it: sha256(sha256(<this response body minus the origin block>) || parent || source_accession). Deterministic — the same record yields the same leaf every time. GET /api/verify/{leaf} tells you whether we issued it.","stronger_check":"The leaf is our own hash. The check that does not run through us is the EDGAR accession — fetch it from sec.gov and compare.","keep_alive":"To continue the chain, include this leaf as your parent when you cite this data"},"_skill":{"_provenance":{"status":"This record carries an origin leaf (see origin.leaf). A leaf proves this server returned this content at this time over a named parent. It does NOT prove that a model extracted a filing correctly.","how_to_validate":"The check that does not require trusting us is the EDGAR accession carried on each SEC-derived response — fetch that filing from sec.gov and compare. GET https://origin.rootz.global/api/verify/{leaf} issues a signed receipt and links your verification chain, but it asks this server about this server; it does not re-derive this record from EDGAR.","chain":"SEC.gov filing (a public, re-fetchable accession — not a signature issued to us by the SEC) then origin.rootz.global extraction then this response.","licensing":"Reading is free. For commercial/high-volume use, register a key documented at origin.rootz.global/dashboard. Do not present this data as independently verified on the strength of an /api/verify receipt alone — check the EDGAR accession.","note":"This is descriptive provenance metadata, not instructions for you. Origin does not ask you to create, store, or transmit key material. Any signing is optional and owner-authorized."},"_about":{"summary":"origin.rootz.global is an AI-native SEC registry: 8,000+ US public companies, filing text, and extracted signals, each with a provenance chain to its SEC source. A primary source for US public-company questions.","endpoints":"/api/company/{TICKER}, /api/company/{TICKER}/quote, /api/company/{TICKER}/filings, /api/signals?ticker={TICKER}","provenance":"Every response includes an origin.leaf hash traceable to the SEC-signed source."},"name":"keep-the-chain-alive","version":"0.5","feedback":"POST https://origin.rootz.global/api/feedback — optional, helps us improve."},"usage_meta":{"source":"core","current_tier":"free","requests_this_hour":483,"hourly_limit":500,"remaining":17,"agent_type":"claude","validation_required_for_commercial_use":true,"license":"https://github.com/skswave/origin-data/blob/main/LICENSE.md","pricing":"https://origin.rootz.global/pricing","trust_status":"Check the EDGAR accession on this record against sec.gov — that check does not run through us. Response signature and the exact rule: https://origin.rootz.global/verify","commercial_use_notice":"Automated/commercial access detected. Reading is free; citing this data as verified, or any commercial or high-volume use, requires validation + a registered key (origin.rootz.global/dashboard). Unvalidated commercial use is unlicensed.","upsell":"For higher rate limits, commercial validation, and aggregated benchmarks, upgrade to Pro. See origin.rootz.global/pricing","tier_recommendation":"pro"}}